U.S. stocks are rallying after financial markets worldwide got a shot of adrenaline from an encouraging update on U.S.

A close look at the favourites for the ochre jersey, as 2024 winner Williams to face stiff competition from Plapp, Vine and ...

Defending champion Aryna Sabalenka held on for a tough second-round win at the Australian Open on Wednesday, but last year's ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

King Charles and Queen Camilla's six-day tour in Australia cost £317,031, which is less than half the cost of his mother, Queen Elizabeth's same day tour in 2006 and less than a quarter of her ...

Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...

(NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step forward ...

Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%. I've been on 50 cruises. Here are 5 things I never buy ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...